Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
3576
DELISTED
Molecular Templates, Inc.
MTEM
| $113K | ﹤0.01% |
23,025
-15,820
| -41% | -$131K |
|
|
BGMS
3577
Bio Green Med Solution Inc
BGMS
$5.1M
| $112K | ﹤0.01% |
47
| – | – |
|
|
KNDI
3578
Kandi Technologies Group
KNDI
$62.6M
| $112K | ﹤0.01% |
48,700
+4,100
| +9% | +$10.7K |
|
3579
Pyxis Oncology
PYXS
$191M
| $112K | ﹤0.01% |
83,600
-45,202
| -35% | -$67.8K |
|
3580
ReWalk Robotics
LFWD
$21.8M
| $112K | ﹤0.01% |
1,748
+443
| +34% | +$32.4K |
|
3581
Regis Corp
RGS
$69.3M
| $111K | ﹤0.01% |
+4,545
| New | +$108K |
|
3582
Scienjoy Holding
SJ
$39.1M
| $111K | ﹤0.01% |
56,500
-15,400
| -21% | -$27.5K |
|
|
KA
3583
DELISTED
Kineta, Inc. Common Stock
KA
| $111K | ﹤0.01% |
17,516
+7,699
| +78% | +$86.6K |
|
3584
Arts-Way Manufacturing Co
ARTW
$13.3M
| $110K | ﹤0.01% |
57,074
-6,929
| -11% | -$13.8K |
|
3585
Dominari Holdings
DOMH
$70.8M
| $110K | ﹤0.01% |
33,526
+600
| +2% | +$2.89K |
|
3586
Westwater Resources
WWR
$75.2M
| $110K | ﹤0.01% |
139,454
-9,940
| -7% | -$10.6K |
|
|
YJ
3587
Yunji
YJ
$9.56M
| $110K | ﹤0.01% |
3,365
+216
| +7% | +$6.82K |
|
|
DXYN
3588
DELISTED
Dixie Group Inc
DXYN
| $110K | ﹤0.01% |
140,500
+21,700
| +18% | +$21.5K |
|
3589
a.k.a. Brands
AKA
$119M
| $109K | ﹤0.01% |
7,183
+91
| +1% | +$1.81K |
|
3590
Arqit Quantum
ARQQ
$413M
| $109K | ﹤0.01% |
+1,212
| New | +$178K |
|
3591
Savara
SVRA
$1.08B
| $109K | ﹤0.01% |
70,100
+100
| +0.1% | +$137 |
|
|
SEAC
3592
DELISTED
Seachange International Inc
SEAC
| $109K | ﹤0.01% |
11,550
+90
| +0.8% | +$764 |
|
|
LEJU
3593
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $109K | ﹤0.01% |
81,999
-11,500
| -12% | -$17.4K |
|
|
AACG
3594
ATA Creativity
AACG
$48M
| $108K | ﹤0.01% |
84,444
-8,900
| -10% | -$15K |
|
|
SOGP
3595
Sound Group
SOGP
$46.1M
| $108K | ﹤0.01% |
17,070
+500
| +3% | +$3K |
|
3596
Tantech Holdings
TANH
$5.27M
| $108K | ﹤0.01% |
1,256
-127
| -9% | -$15.2K |
|
3597
Traws Pharma
TRAW
$8.12M
| $108K | ﹤0.01% |
6,706
-1,498
| -18% | -$28.3K |
|
|
JXG
3598
JX Luxventure
JXG
$85.6M
| $108K | ﹤0.01% |
220
-16
| -7% | -$7.51K |
|
3599
Escalade
ESCA
$284M
| $107K | ﹤0.01% |
10,530
-200
| -2% | -$2.08K |
|
3600
Intellicheck
IDN
$75.9M
| $107K | ﹤0.01% |
53,700
-1,600
| -3% | -$3.48K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.